ISOVUE 300 612 mg/mL

ISOVUE 300 612 mg/mL is an iodinated contrast media used for diagnostic imaging procedures. This intravenous solution aids in enhancing visibility during X-ray and CT scans.

ISOVUE 300 612 mg/mL is primarily used as a contrast agent to improve the clarity of images during radiographic examinations. It is commonly administered intravenously to highlight blood vessels, organs, and tissues, making it easier for healthcare professionals to detect abnormalities. This solution is often utilized in procedures such as angiography, computed tomography (CT) scans, and other diagnostic imaging techniques.

When administered, ISOVUE 300 612 mg/mL may cause a temporary warming sensation or a metallic taste in the mouth. Some individuals might experience mild discomfort at the injection site. These effects are generally short-lived and subside quickly.

ISOVUE 300 612 mg/mL should be used with caution in individuals with a history of allergic reactions to iodinated contrast media. It is essential to inform healthcare providers about any known allergies or medical conditions before administration. Proper handling and storage are crucial to maintain the integrity and effectiveness of the solution.

ISOVUE 300 612 mg/mL may interact with certain medications, particularly those that affect kidney function. It is important to disclose all current medications to healthcare providers to avoid potential interactions. Additionally, caution should be exercised when combining this contrast media with other intravenous solutions.